Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $39.98 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.